Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Obesity and vascular response to mental stress with angiotensin II receptor blockade
RBR-8mxb7wCompleted
- Sponsor
- Universidade Federal Fluminense
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of losartan in obesity (2 arms), sponsored by Universidade Federal Fluminense. Primary endpoint: Endothelial function by flow-mediated dilation. Started Aug 2017; status: completed.
02
Drugs
losartan
03
Conditions
obesity
Beyond the preview
Go deeper on RBR-8mxb7w.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-8mxb7w.